தேசிய புற்றுநோய் நிறுவனம் மானியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய புற்றுநோய் நிறுவனம் மானியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய புற்றுநோய் நிறுவனம் மானியம் Today - Breaking & Trending Today

Social media may influence parents' views on HPV vaccination


Date Time
Social media may influence parents’ views on HPV vaccination
Penn State College of Medicine researchers determined that misinformation on social media may affect parents’ willingness to have their children vaccinated against human papillomavirus.
Image: Penn State
HERSHEY, Pa. – Studies by Penn State College of Medicine researchers demonstrate that misinformation on social media may affect parents’ willingness to have their children vaccinated against human papillomavirus (HPV). They also found that some parents are in favor of establishing standards for combating HPV vaccine misinformation on social media.
Prior research conducted by the Pew Research Center showed that 72% of adults use social media, and many rely on it for news and information. However, misleading and inaccurate information is easily shared online and can be especially harmful when it comes to health-related issues. ....

United States , Anne Marie Dyer , Katherine Spanos , William Calo , Noel Brewer , Susan Alton Dailey , Jennifer Moss , Jennifer Kraschnewski , Marjorie Margolis , Ashley Wong , Melissa Gilkey , Centers For Disease , Gillings School Of Global Public Health , Penn State Cancer Institute , American Cancer Society Institutional Research Grant , Penn State College Of Medicine , Pew Research Center , Hutchinson Institute For Cancer Outcomes Research , National Cancer Institute Grant , Penn State College , Public Health Sciences , Penn State Cancer , Hispanic Black , Marie Dyer , Gillings School , Global Public Health ,

Potential ways to improve survival for certain cancer patients who receive fragmented care


Date Time
Potential ways to improve survival for certain cancer patients who receive fragmented care
New study designed to address health care fragmentation identifies risk factors for readmission to a different hospital from where pancreatic, liver, or stomach cancer operations were initially performed.
Key Takeaways
Pancreatic, liver, bile duct, and stomach cancer operations are inherently complex and initially often take place at large cancer centers where surgical teams perform a large volume of procedures.
Readmission to a different hospital from where patients had these operations initially performed markedly increases death risk.
There are ways to address care fragmentation with newly identified risk factors for readmission; cancer hospitals should seek to determine safe sites of care for readmissions after these types of operations. ....

United States , New York , Memorial Sloan Kettering Cancer Center , Ningying Wu , Davidg Brauer , Williamg Hawkins , Chetw Hammill , Matthewr Keller , Grahama Colditz , Dominice Sanford , National Center , Americas Association In Miami , National Institutes Of Health , Washington University School Of Medicine , Journal Of The American College Surgeons , Translational Sciences , American College Of Surgeons , National Cancer Institute Grant , Agency For Healthcare Research , American College , Washington University School , Healthcare Cost , Utilization Project , National Cancer Institute , National Institutes , Advancing Translational Sciences ,

Potential ways to improve survival for cancer patients who receive fragmented care


Loading video.
VIDEO: Key findings are summarized by the study s lead investigator, David G. Brauer, MD, MPHS.
view more 
Credit: American College of Surgeons
Key takeaways
Pancreatic, liver, bile duct, and stomach cancer operations are inherently complex and initially often take place at large cancer centers where surgical teams perform a large volume of procedures.
Readmission to a different hospital from where patients had these operations initially performed markedly increases death risk.
There are ways to address care fragmentation with newly identified risk factors for readmission; cancer hospitals should seek to determine safe sites of care for readmissions after these types of operations. ....

United States , New York , Memorial Sloan Kettering Cancer Center , Ningying Wu , Davidg Brauer , Williamg Hawkins , Chetw Hammill , Matthewr Keller , Grahama Colditz , Dominice Sanford , National Center , Americas Association In Miami , National Institutes Of Health , Washington University School Of Medicine , Journal Of The American College Surgeons , Translational Sciences , American College Of Surgeons , National Cancer Institute Grant , Agency For Healthcare Research , American College , Washington University School , Healthcare Cost , Utilization Project , National Cancer Institute , National Institutes , Advancing Translational Sciences ,

Cancer immunotherapy approach targets common genetic alteration


 E-Mail
IMAGE: Novel cancer immunotherapy approach inverts a missing gene copy into an immune cell-activating signal.
view more 
Credit: Elizabeth Cook
Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are missing one gene copy, called loss of heterozygosity (LOH), was developed by researchers at the Ludwig Center, Lustgarten Laboratory and the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center.
Genes have two alleles, or copies, with one copy inherited from each parent. Cancer-related genetic alterations commonly involve the loss of one of these gene copies. ....

United States , Shibin Zhou , Emily Han , Nickolas Papadopoulos , Michael Hwang , Astrazeneca Medimmune Amplimmune , Jacqueline Douglass , Johns Hopkins , Alexander Pearlman , Sarah Dinapoli , Bert Vogelstein , Kenneth Kinzler , Suman Paul , Sandra Gabelli , Chetan Bettegowda , Maximilian Konig , Chung Hsiue , Johns Hopkins University , Commonwealth Fund , Bloomberg Kimmel Institute For Cancer Immunotherapy , Dk Ludwig Fund For Cancer Research , Johns Hopkins Kimmel Cancer Center , Bristol Myers Squibb , National Cancer Institute Grant , Dracen Pharmaceuticals , National Institutes Of Health ,